| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/07/2005 | EP1571214A2 Immunogenic detoxified mutant toxin |
| 09/07/2005 | EP1571195A1 External composition containing highly unsaturated fatty acid or its salt or ester |
| 09/07/2005 | EP1571146A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 09/07/2005 | EP1571145A1 Substituted piperidine compounds for use as H3 histamine receptor antagonists |
| 09/07/2005 | EP1571142A1 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production |
| 09/07/2005 | EP1570860A1 Antagonist and agonist binding to strong binding site of chemokine receptor |
| 09/07/2005 | EP1569937A2 C-6 modified indazolylpyrrolotriazines |
| 09/07/2005 | EP1569679A1 Chaperonin 10 immunosuppression |
| 09/07/2005 | EP1569660A2 C-type lectin binding molecules, identification and uses thereof |
| 09/07/2005 | EP1569656A2 Phosphoantigens for regulating an immune response |
| 09/07/2005 | EP1569650A1 Use of levocetirizine for the treatment of persistent allergic rhinitis |
| 09/07/2005 | EP1569640A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 09/07/2005 | EP1501834B1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
| 09/07/2005 | EP1458717B1 Aroyl pyridinones |
| 09/07/2005 | EP1438291B1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 09/07/2005 | EP1377589B1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 09/07/2005 | EP1370279B1 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 09/07/2005 | EP1335740B1 Preparations having effect against allergic symptoms and their manufacturing method |
| 09/07/2005 | EP1326853B1 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 09/07/2005 | EP1307438B1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field |
| 09/07/2005 | EP1151109B1 Fucosyl transferase gene |
| 09/07/2005 | EP1023308B1 Inhibitors of nucleoside metabolism |
| 09/07/2005 | EP0842282B1 Alfa-beta c4bp-type recombinant heteromultimeric proteins |
| 09/07/2005 | CN1665934A GNTIII(UDP-N-acetylglucosamine:beta-D mannoside beta (1, 4)-N-acetylglucosaminyltransferase III) expression in plants |
| 09/07/2005 | CN1665931A Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence |
| 09/07/2005 | CN1665929A Circular dumbbell decoy oligodeoxynucleotides (CDODN) containing DNA bindings sites of transcription |
| 09/07/2005 | CN1665831A Novel compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| 09/07/2005 | CN1665829A Nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 09/07/2005 | CN1665818A N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 09/07/2005 | CN1665817A Process for preparing certain pyrrolotriazine compounds |
| 09/07/2005 | CN1665810A Inhibitors of JAK and CDK2 protein kinases |
| 09/07/2005 | CN1665809A Azaindoles |
| 09/07/2005 | CN1665808A Thiadiazoles or oxadiazoles and their use as inhibitors of JAK protein kinase |
| 09/07/2005 | CN1665804A 4, 4-disubstituted piperidine derivatives having CCR3 antagonism |
| 09/07/2005 | CN1665800A Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/07/2005 | CN1665780A Tricyclic steroid hormone nuclear receptor modulators |
| 09/07/2005 | CN1665554A Compounds and method for coating surfaces in a haemocompatible manner |
| 09/07/2005 | CN1665537A Use of CETP inhibitors and optionally HMG COA reductable inhibitors and/or antihypertensive agents |
| 09/07/2005 | CN1665535A Perylenequinones for use with immunotherapy agents |
| 09/07/2005 | CN1665534A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 09/07/2005 | CN1665533A Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 09/07/2005 | CN1665531A Cancer vaccines and methods of using the same |
| 09/07/2005 | CN1665529A Method to enhance an immune response of nucleic acid vaccination |
| 09/07/2005 | CN1665526A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 09/07/2005 | CN1665524A Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/07/2005 | CN1665508A Use of pyrazolo[4, 3-d]pyrimidines |
| 09/07/2005 | CN1665401A Vitamin-containing system for stabilising the immune response of animals |
| 09/07/2005 | CN1663963A Hybrid interferon compositions and methods of use |
| 09/07/2005 | CN1663959A Beta-glucan peptide and its preparing process and application |
| 09/07/2005 | CN1663610A Lysozyme preparation |
| 09/07/2005 | CN1663593A Glucoside active site LWD-b in Liuwei Dihuang decoction, its preparation and medical usage |
| 09/07/2005 | CN1217938C Bis-arylsulfones |
| 09/07/2005 | CN1217926C Novel vitamin D analogues |
| 09/07/2005 | CN1217918C Aminocyclohexyl ether compounds and uses thereof |
| 09/07/2005 | CN1217698C Activation and protection of T-cells (CD4+ and CD8+) using and H2 receptor agonist and other T-cell activating agents |
| 09/07/2005 | CN1217697C Peptide antagonists of zonulin and methods for use of same |
| 09/06/2005 | US6939959 Efficient protein expression system |
| 09/06/2005 | US6939886 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1) |
| 09/06/2005 | US6939883 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 09/06/2005 | US6939872 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 09/06/2005 | US6939860 Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds |
| 09/06/2005 | US6939559 Pharmaceutical composition for application to mucosa |
| 09/06/2005 | US6939550 Storage stability |
| 09/06/2005 | US6939541 Polypeptide for use in the treatment of viral diseases and cancer |
| 09/06/2005 | US6939539 present invention relates to an improved composition of copolymer-1 comprising copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons |
| 09/06/2005 | CA2278025C Aqueous suspension for nasal administration |
| 09/06/2005 | CA2193329C Water soluble rapamycin esters |
| 09/01/2005 | WO2005080575A1 Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-length virus genome replicative cell having the nucleic acid construct transferred thereinto and method of constructing hepatitis c viral particles |
| 09/01/2005 | WO2005080553A1 Cell-associated physiologically active substance and cell culture supplement |
| 09/01/2005 | WO2005080385A1 Indanol derivative |
| 09/01/2005 | WO2005079842A1 Immunological adjuvant |
| 09/01/2005 | WO2005079814A1 A pharmaceutical composition used for treating recurrent spontaneous abortion and method thereof |
| 09/01/2005 | WO2005079788A1 Amino alcohol compound |
| 09/01/2005 | WO2005079506A2 Systemic immune activation method using nucleic acid-lipid complexes |
| 09/01/2005 | WO2005079423A2 Chemically programmable immunity |
| 09/01/2005 | WO2004048512A3 Novel proteins and nucleic acids encoding same |
| 09/01/2005 | WO2003018759A3 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same |
| 09/01/2005 | WO2002083873A3 Enzymes |
| 09/01/2005 | US20050192327 Myocardial infarction or its recurrence is treated with telmisartan an ACE inhibitor |
| 09/01/2005 | US20050192326 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril |
| 09/01/2005 | US20050192318 5-[4-Methylsulfonyloxy-2-(S)-(3,4-dichlorophenyl)butyl]-10-cyano-3-(R)-methyl-6-oxo-3,4,5,6-tetrahydro-2H-benzo[b][1,5]oxazocine as antidepressant |
| 09/01/2005 | US20050192238 Modulation of the expression of genes dependent on stat-1 |
| 09/01/2005 | US20050192232 E.g.,N[(R)-3-dodecanoyloxytetradecanoylamino]-C-aspartic acid, alpha-N-{(4R)-5-hydroxy-4-[(R)-3-hydroxytetradecanoyl- amino]pentyl}amide; grafting antigens to modulate immune response and on a pharmaceutical carrier or antibiotic to enhance therapeutic effect or targetting aqueous conjugate injections |
| 09/01/2005 | US20050192214 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 09/01/2005 | US20050192208 Cardiovascular disorders; antiarrhythmia agents; sodium channel moderators ; potassium channel moderators; prevent fibrillation |
| 09/01/2005 | US20050191747 Recombinant bovine immunodeficiency virus based gene transfer system |
| 09/01/2005 | US20050191696 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products |
| 09/01/2005 | US20050191695 Documentation means for repertoires of NKR immunoreceptors and/or activatory or non-inhibitory immunoreceptor counterparts of NKR immunoreceptors |
| 09/01/2005 | US20050191690 Membrane proteins for identifying modulators for prevention and treatment of infection, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders |
| 09/01/2005 | US20050191617 Pramyxovirusl vectors encoding antibody and utilization thereof |
| 09/01/2005 | US20050191345 Temperature-sensitive liposomal formulation |
| 09/01/2005 | US20050191310 Novel compositions of saponin adjuvants and excipients |
| 09/01/2005 | US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 09/01/2005 | US20050191300 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 09/01/2005 | US20050191290 Cell with immunoglobulin-free light chain (Ig-LC) receptor capable of activating signal transduction pathway upon binding to receptor; mast cell is activated and stimulated to degranulate; skin disorders, asthma, psoriasis, inflammatory bowel disease, rheumatoid arthritis, lupus, Sjogren*s syndrome |
| 09/01/2005 | US20050191267 Mulberry extract; whitening effects for darkened skin through antityrosinase activity, antioxidant and anti-inflammatory properties |
| 09/01/2005 | DE102004005788A1 Zubereitungen enthaltend Echinacea-Auszüge und Thiocyanat Preparations containing Echinacea extracts and thiocyanate |
| 09/01/2005 | CA2558685A1 Nucleic acid construct containing fulllength genome of human hepatitis c virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferredthereinto and method of producing hepatitis c viral particle |
| 09/01/2005 | CA2557539A1 Indanol derivative |
| 09/01/2005 | CA2556803A1 T cell immune response inhibitor |